The C. Light TSLO (including software and machine learning algorithms) could efficiently, objectively, and non-invasively aid in the prognosis and monitoring of multiple sclerosis (MS) by measuring neurological activity by imaging the retina, which is the also the front of the brain. It extracts eye motion at the cellular level - 150x more accurately than any pupil-tracking device on the market. Eye motion is then summarized within a TSLO readout report, providing actionable information to the patient care team.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2014
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at C. Light